76 related articles for article (PubMed ID: 17492124)
1. A patient-specific in vivo tumor and normal tissue model for prediction of the response to radiotherapy.
Stamatakos G; Antipas VP; Ozunoglu NK
Methods Inf Med; 2007; 46(3):367-75. PubMed ID: 17492124
[TBL] [Abstract][Full Text] [Related]
2. A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomide.
Stamatakos GS; Antipas VP; Uzunoglu NK
IEEE Trans Biomed Eng; 2006 Aug; 53(8):1467-77. PubMed ID: 16916081
[TBL] [Abstract][Full Text] [Related]
3. Simulating chemotherapeutic schemes in the individualized treatment context: the paradigm of glioblastoma multiforme treated by temozolomide in vivo.
Stamatakos GS; Antipas VP; Uzunoglu NK
Comput Biol Med; 2006 Nov; 36(11):1216-34. PubMed ID: 16207487
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma multiforme treated by the chemotherapeutic agent temozolomide in vivo: a 4D simulation model of the tumor response.
Antipas VP; Stamatakos GS; Uzunoglu NK
Conf Proc IEEE Eng Med Biol Soc; 2005; 2005():6100-3. PubMed ID: 17281655
[TBL] [Abstract][Full Text] [Related]
5. A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density.
Stamatakos GS; Antipas VP; Uzunoglu NK; Dale RG
Br J Radiol; 2006 May; 79(941):389-400. PubMed ID: 16632619
[TBL] [Abstract][Full Text] [Related]
6. A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation.
Dionysiou DD; Stamatakos GS; Uzunoglu NK; Nikita KS; Marioli A
J Theor Biol; 2004 Sep; 230(1):1-20. PubMed ID: 15275995
[TBL] [Abstract][Full Text] [Related]
7. Modeling tumor growth and irradiation response in vitro--a combination of high-performance computing and web-based technologies including VRML visualization.
Stamatakos GS; Zacharaki EI; Makropoulou MI; Mouravliansky NA; Marsh A; Nikita KS; Uzunoglu NK
IEEE Trans Inf Technol Biomed; 2001 Dec; 5(4):279-89. PubMed ID: 11759834
[TBL] [Abstract][Full Text] [Related]
8. An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumor to chemotherapy: Mimicking a clinical study.
Stamatakos GS; Kolokotroni EA; Dionysiou DD; Georgiadi ECh; Desmedt C
J Theor Biol; 2010 Sep; 266(1):124-39. PubMed ID: 20515697
[TBL] [Abstract][Full Text] [Related]
9. Computer simulation of fractionated radiotherapy: further results and their relevance to percutaneous irradiation and brachytherapy.
Ginsberg T; Ulmer W; Düchting W
Strahlenther Onkol; 1993 May; 169(5):304-10. PubMed ID: 8503090
[TBL] [Abstract][Full Text] [Related]
10. Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology.
Yang Y; Xing L
Med Phys; 2005 Dec; 32(12):3666-77. PubMed ID: 16475766
[TBL] [Abstract][Full Text] [Related]
11. Radiogenic responses of normal cells induced by fractionated irradiation--a simulation study. Part II. Late responses.
Düchting W; Ulmer W; Ginsberg T; Kikhounga-N'Got O; Saile C
Strahlenther Onkol; 1995 Sep; 171(9):525-33. PubMed ID: 7570301
[TBL] [Abstract][Full Text] [Related]
12. MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation.
Park SS; Chunta JL; Robertson JM; Martinez AA; Oliver Wong CY; Amin M; Wilson GD; Marples B
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):885-92. PubMed ID: 21489704
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy planning for glioblastoma based on a tumor growth model: improving target volume delineation.
Unkelbach J; Menze BH; Konukoglu E; Dittmann F; Le M; Ayache N; Shih HA
Phys Med Biol; 2014 Feb; 59(3):747-70. PubMed ID: 24440875
[TBL] [Abstract][Full Text] [Related]
14. Modeling of radiogenic responses induced by fractionated irradiation in malignant and normal tissue.
Düchting W; Ginsberg T; Ulmer W
Stem Cells; 1995 May; 13 Suppl 1():301-6. PubMed ID: 7488961
[TBL] [Abstract][Full Text] [Related]
15. Prediction of radiation-induced normal tissue complications in radiotherapy using functional image data.
Nioutsikou E; Partridge M; Bedford JL; Webb S
Phys Med Biol; 2005 Mar; 50(6):1035-46. PubMed ID: 15798307
[TBL] [Abstract][Full Text] [Related]
16. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
18. Radiogenic responses of normal tissue induced by fractionated irradiation--a simulation study. I. Acute effects.
Düchting W; Ulmer W; Ginsberg T; Saile C
Strahlenther Onkol; 1995 Aug; 171(8):460-7. PubMed ID: 7652669
[TBL] [Abstract][Full Text] [Related]
19. Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
Miralbell R; Mornex F; Greiner R; Bolla M; Storme G; Hulshof M; Bernier J; Denekamp J; Rojas AM; Pierart M; van Glabbeke M; Mirimanoff RO
J Clin Oncol; 1999 Oct; 17(10):3143-9. PubMed ID: 10506611
[TBL] [Abstract][Full Text] [Related]
20. Computer simulation and modelling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy.
Düchting W; Ulmer W; Lehrig R; Ginsberg T; Dedeleit E
Strahlenther Onkol; 1992 Jun; 168(6):354-60. PubMed ID: 1320297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
